Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
Spaces That Support: Patient-Centered Design for Modern Reproductive Health
Modernization of Buildings Require Collaboration Across All Disciplines
Children's Health Announces Plans for RedBird Specialty Center in Texas
How Can Healthcare Facilities Use Efficiency to Drive Climate and Health Goals?
El Camino Health Rehabilitation Hospital Officially Tops Out